Bionexus Gene Lab COO Liong Tai Tan resigns; Lee Su-Leng Tan appointed COO

BioNexus Gene Lab Corp

Liong Tai Tan resigned as COO and director effective August 31, 2023; no disagreement with company.
Board approved Lee Su-Leng Tan as COO effective September 1, 2023; he is not a director.
Lee Su-Leng Tan, aged 40, has over 20 years of experience in life sciences, hospitality, and property.
New COO entered employment agreement dated August 15, 2023, with annual compensation of $24,000.
Tan previously served as Chief Commercial Officer at Dryox Health and Managing Director at Biotechnology Group.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Liong Tai Tan

Director

BGLC · BioNexus Gene Lab Corp

Effective: 2023-08-31
Filed: September 7, 2023, 7:59 PM ET

The Company and Mr. Liong Tai Tan agreed that the resignations would be effective August 31, 2023.

Appointed

Lee Su-Leng Tan

Chief Operating Officer

BGLC · BioNexus Gene Lab Corp

Effective: 2023-09-01
Filed: September 7, 2023, 7:59 PM ET

the Board of Directors of the Company approved the appointment of Mr. Lee Su-Leng Tan as the Chief Operating Officer and not a director, effective September 1, 2023.

Departed

Liong Tai Tan

Chief Operating Officer

BGLC · BioNexus Gene Lab Corp

Effective: 2023-08-31
Successor: Lee Su-Leng Tan
Filed: September 7, 2023, 7:59 PM ET

Mr. Liong Tai Tan, the Chief Operating Officer and a member of the Board of Directors, notified Bionexus Gene Lab Corp. (“the Company”) of his desire to resign from his position at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Liong Tai Tan resigned as Director at BioNexus Gene Lab Corp.

Action: resigned
Role: Director

Exact text from the filing

The Company and Mr. Liong Tai Tan agreed that the resignations would be effective August 31, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lee Su-Leng Tan was appointed as Chief Operating Officer at BioNexus Gene Lab Corp.

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

the Board of Directors of the Company approved the appointment of Mr. Lee Su-Leng Tan as the Chief Operating Officer and not a director, effective September 1, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Liong Tai Tan resigned as Chief Operating Officer at BioNexus Gene Lab Corp.

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

Mr. Liong Tai Tan, the Chief Operating Officer and a member of the Board of Directors, notified Bionexus Gene Lab Corp. (“the Company”) of his desire to resign from his position at the Company.

View on SEC.gov

BioNexus Gene Lab Corp filing history →

Source: SEC EDGAR

accession 0001477932-23-006695

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.